IVF company Virtus Health receives $607m takeover offer from BGH Group

IVF company Virtus Health receives $607m takeover offer from BGH Group

Virtus Health (ASX: VRT) chief executive officer Kate Munnings.

Assisted reproductive services company Virtus Health (ASX: VRT) has received a non-binding takeover offer from private equity firm BGH Capital valuing the target at approximately $607 million, representing a 36 per cent premium to yesterday's closing price.

BGH has expressed interest in acquiring 100 per cent of VRT shares at $7.10 per share and has already acquired a 9.99 per cent stake, as well as entering a total return swap with UBS that has yet to settle for an option to acquire a further 10 per cent.

The proposed price is just shy of the highs reached by Virtus in August, prior to a steady decline that followed the release of its annual results later that month when Virtus reported a doubling of earnings in FY21 but noted heightened COVID-related infection controls were contributing to treatment deferrals.

In August the company also announced plans to acquire Adora Fertility from Healius (ASX: HLS) for $45 million, but that has been scuppered to date by concerns from the competition watchdog.

Virtus is one of the world's top five assisted reproductive services companies with market-leading positions in Australia, Ireland and Denmark, as well as a growing presence in Singapore and the UK.

BGH has stated its offer price will be offered to all Virtus shareholders entirely in cash, and that it also proposes to provide a cash and scrip alternative to major fertility specialist shareholders and certain other affiliated shareholders to enable them to continue their investment in Virtus.

However, BGH still needs to complete due diligence and has set the condition that for a deal to go ahead Virtus must not sell or agree to sell any material assets, and that there ought not be any material change to its prospects or financial markets, among other conditions including the unanimous support of the Virtus board.

Virtus has advised that shareholders do not need to take any action at this time, that it has commenced an assessment of BGH’s proposal, and that there is no certainty the proposal will result in a transaction.

Virtus has appointed Jefferies (Australia) Limited as financial adviser and Gilbert + Tobin as legal adviser.

 

Get our daily business news

Sign up to our free email news updates.

Please tick to verify that you are not a robot

 

Help us deliver quality journalism to you.
As a free and independent news site providing daily updates
during a period of unprecedented challenges for businesses everywhere
we call on your support

Naturally Good: Showcasing Australia’s natural and organic leaders
Partner Content
With just days to go until Naturally Good, Australia’s leading trade exhibition d...
Naturally Good
Advertisement

Related Stories

Baby Bunting shares plummet after 'unprecedentedly low' sales

Baby Bunting shares plummet after 'unprecedentedly low' sales

Baby Bunting Group (ASX: BBN) has seen shares tumble by 24pc this m...

Lewis Land’s $1.5b Harbour Shores to drive decade-long transformation of Harbour Town precinct

Lewis Land’s $1.5b Harbour Shores to drive decade-long transformation of Harbour Town precinct

Sydney-based Lewis Land Group is preparing for a decade-long transf...

Amcal owner Sigma will give shares to Chemist Warehouse in exchange for $3b supply deal

Amcal owner Sigma will give shares to Chemist Warehouse in exchange for $3b supply deal

The owner of such pharmacy retail brands as Amcal, Discount Drug St...

Cancer-fighting biotech ImmVirX secures $15m from OneVentures

Cancer-fighting biotech ImmVirX secures $15m from OneVentures

A Newcastle-based biotechnology company developing a virus that can...